< 1 minute read
Sep. 18, 2021
RM-018: A KRAS(G12C)ON-cyclophilin A Tri-Complex Inhibitor
RM-018
KRAS(G12C)ON-cyclophilin A tri-complex inh. overcomes KRAS resist. mut. in PDX model natural product related (sanglifehrin); undiscl. Cancer Discov., Apr. 6, 2021 Revolution Medicines, Redwood City, CA
Loading...
